A detailed history of Ingalls & Snyder LLC transactions in Walgreens Boots Alliance, Inc. stock. As of the latest transaction made, Ingalls & Snyder LLC holds 298,209 shares of WBA stock, worth $2.74 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
298,209
Holding current value
$2.74 Million
% of portfolio
0.1%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$8.26 - $12.16 $2.46 Million - $3.63 Million
298,209 New
298,209 $2.67 Million
Q3 2020

Oct 21, 2020

SELL
$34.67 - $43.16 $222,581 - $277,087
-6,420 Closed
0 $0
Q1 2020

Apr 22, 2020

SELL
$41.02 - $59.59 $22,971 - $33,370
-560 Reduced 8.02%
6,420 $294,000
Q4 2019

Jan 15, 2020

SELL
$52.08 - $62.72 $54,684 - $65,856
-1,050 Reduced 13.08%
6,980 $412,000
Q3 2019

Oct 16, 2019

SELL
$49.29 - $58.06 $98,580 - $116,120
-2,000 Reduced 19.94%
8,030 $444,000
Q2 2019

Jul 11, 2019

SELL
$49.34 - $63.49 $37,005 - $47,617
-750 Reduced 6.96%
10,030 $548,000
Q1 2019

Apr 11, 2019

SELL
$59.79 - $74.43 $11,958 - $14,886
-200 Reduced 1.82%
10,780 $682,000
Q4 2018

Jan 24, 2019

SELL
$65.26 - $85.69 $61,997 - $81,405
-950 Reduced 7.96%
10,980 $750,000
Q3 2018

Oct 24, 2018

SELL
$60.76 - $73.81 $46,056 - $55,947
-758 Reduced 5.97%
11,930 $870,000
Q2 2018

Aug 10, 2018

SELL
$59.7 - $68.0 $146,265 - $166,600
-2,450 Reduced 16.18%
12,688 $761,000
Q1 2018

Apr 17, 2018

SELL
$65.43 - $80.27 $45,081 - $55,306
-689 Reduced 4.35%
15,138 $991,000
Q4 2017

Jan 19, 2018

SELL
$64.48 - $76.95 $24,631 - $29,394
-382 Reduced 2.36%
15,827 $1.15 Million
Q3 2017

Oct 20, 2017

BUY
$77.22 - $82.74 $1.25 Million - $1.34 Million
16,209
16,209 $1.25 Million

Others Institutions Holding WBA

About Walgreens Boots Alliance, Inc.


  • Ticker WBA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Pharmaceutical Retailers
  • Shares Outstandng 864,812,992
  • Market Cap $7.95B
  • Description
  • Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and beauty retail company. It operates through two segments, the United States and International. The United States segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products...
More about WBA
Track This Portfolio

Track Ingalls & Snyder LLC Portfolio

Follow Ingalls & Snyder LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ingalls & Snyder LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ingalls & Snyder LLC with notifications on news.